期刊文献+

膀胱移行细胞癌组织中微血管密度与其生物学行为及预后的关系 被引量:6

The relationship between microvessel density derived from transitional cell carcinonma of bladder tissues and its biological behavior and prognosis
下载PDF
导出
摘要 目的:通过检测膀胱移行细胞癌组织中微血管密度(MVD),探讨肿瘤新生血管形成与膀胱移行细胞癌发生、发展及预后的关系。方法:应用免疫组织化学技术检测61例膀胱移行细胞癌组织及23例癌旁组织中第Ⅷ因子相关抗原表达,并计数MVD。结果:膀胱癌组织中的MVD明显高于正常膀胱组织,并与膀胱移行细胞癌的分级、分期密切相关(P<0.01.F=25.61,29.72)。肿瘤复发组MVD显著高于无复发组(P<0.01,t=3.20)。膀胱移行细胞癌组织高MVD病例的生存率明显低于低MVD的病例(P<0.05,χ2=26.65)。结论:MVD与膀胱移行细胞癌的发生、发展以及预后密切相关,可作为独立的膀胱移行细胞癌的预后判断指标。 AIM:To investigate the relationship between tumor angiogenesis and the occurre nce ,developing and prognosis of bladder transitional cell carcinonma through de tecting microvessel density derived from bladder transitional cell carcinonma. METHODS:The immunohistochemical method(IHC) were used to measure the expressio n of the Factor VIII related antigen in 61 cases of bladder transitional cell ca rcinoma and 23 cases of adjacent tissues nearby the cancer and MVD was counted. RESULTS:The MVD in bladder transitional cell carcinoma group were much higher than those in the adjacent tissue group, MVD positively related to tumor grades and stages(P< 0.01,F=25.61,29.72).MVD in recurrence cases were significantly hig her than that non-recurrence cases(P< 0.01,t=3.20).The survival ratio of patien ts with high MVD was significantly lower than that of patients with low MVD,χ2= 26.65.
出处 《中国临床康复》 CSCD 2003年第26期3586-3587,F003,共3页 Chinese Journal of Clinical Rehabilitation
基金 全军医药卫生科研基金资助(01MA0117)~~
关键词 膀胱移行细胞癌 微血管密度 血管生成 预后 MVD is closely related to the occurrence ,developing ,as well as p rognosis of bladder transitional cell carcinonma.MVD can be used to predict the prognosis of bladder transitional cell carcinoma as an absolute molecular marker s.
  • 相关文献

参考文献2

二级参考文献2

共引文献22

同被引文献35

  • 1刘鲁明,钱华,陈震,林胜友,王泽时.参麦注射液抗肿瘤作用的初步实验研究[J].中国实验方剂学杂志,1996,2(4):11-14. 被引量:28
  • 2[2]Ozdemir E,Kakehi Y,Okuno H,et al.Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas.J Urol 1999;161(4):1359-63
  • 3[3]Weidner N,Semple JP,Welch WR,et al.Tumor Angiogenesis and Metastasiscorrelation in invasive breast carcinoma.N Engl J Med 1991;324(1):1-8
  • 4[4]Delisser HM,Christofidou-Solomidou M,Strierter RM,et al.Involvement of endothelial PECAM-1/CD31 in angiogenesis.Am J Pathol 1997;151(3):671-7
  • 5[6]Kachra Z,Beaulieu E,Delbecchi L,et al.Expression of matrix metalloproteinases and their inhibitors in human brain tumors.Clin Exp Metastasis 1999;17(7):555-66
  • 6[7]Uhm JH,Dooley NP,Villemure JG,et al.Glioma invasion in vitro:regulation by matrix metalloprotease-2 and protein kinase C.Clin Exp Metastasis 1996;14(5):421-33
  • 7[8]Fujimura M,Gasche Y,Morita-Fujimura Y,et al.Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.Brain Res 1999;842(1):92-100
  • 8[11]Assimakopoulou M,Sotiropoulou-Bonikou G,Maraziotis T,et al.Microvessel density in brain tumor.Anticancer Res 1997;17:4747-53
  • 9[12]Takano S,Yoshii Y,Kondo S,et al.Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients.Cancer Res 1996;56(9):2185-90
  • 10[13]Choe G,Park JK,Jouben-steele L,et al.Active matrix metalloproteinase-9 expression is associated with primary glioblastoma subtype.Clin Cancer Res 2002;8(9):2894-901

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部